Casandra
Casandra Test Code AR25067Version 1 (DRAFT)
Performing Lab
COVID‑19 IgG (Spike), Semi‑Quantitative by CIA (Inactive as of 09/03/24)
Also known as: COV19G SQ
Clinical Use
Order TestUse
Use for the detection of IgG antibodies against the spike (S1) protein of SARS‑CoV‑2 that develop in response to natural infection or COVID‑19 vaccination. Not intended for assessment of protective immunity or vaccine response interpretation.
Special Instructions
Not provided.
Limitations
This test is inactive as of September 3, 2024. There is no recommendation for assessing vaccine response; results cannot determine immunity level or differentiate infection vs vaccination.
Test Details
Methodology
Immunoassay (CLIA)
Biomarkers
IgG (Spike)
ProteinSemi‑Quantitative CLIA
Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
Result Turnaround Time
1 day
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Serum
Volume
Not provided
Minimum Volume
Not provided
Similar Tests
Other tests from different labs that may be relevant
SARS-CoV-2 Semi-Quantitative IgG Antibody, Spike
Labcorp
SARS‑CoV‑2 Total Antibody, Spike, Semi‑Quantitative
Quest Diagnostics
SARS-CoV-2 Semi-Quantitative Total Antibody, Spike
Labcorp
SARS‑CoV‑2 Antibodies (IgG Nucleocapsid, IgM Spike), Qualitative
Quest Diagnostics
SARS‑CoV‑2 Antibody (IgG), Nucleocapsid, Qualitative
Quest Diagnostics
SARS-CoV-2 Antibody Profile, Nucleocapsid and Spike
Labcorp
SARS-CoV-2 Antibodies, Nucleocapsid
Labcorp